Literature DB >> 26928945

Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction.

Thomas E Speltz1, Sean W Fanning2, Christopher G Mayne3, Colin Fowler2, Emad Tajkhorshid3, Geoffrey L Greene2, Terry W Moore4.   

Abstract

"Stapled" peptides are typically designed to replace two non-interacting residues with a constraining, olefinic staple. To mimic interacting leucine and isoleucine residues, we have created new amino acids that incorporate a methyl group in the γ-position of the stapling amino acid S5. We have incorporated them into a sequence derived from steroid receptor coactivator 2, which interacts with estrogen receptor α. The best peptide (IC50 =89 nm) replaces isoleucine 689 with an S-γ-methyl stapled amino acid, and has significantly higher affinity than unsubstituted peptides (390 and 760 nm). Through X-ray crystallography and molecular dynamics studies, we show that the conformation taken up by the S-γ-methyl peptide minimizes the syn-pentane interactions between the α- and γ-methyl groups.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  amino acids; conformational analysis; peptides; peptidomimetics; receptors

Mesh:

Substances:

Year:  2016        PMID: 26928945      PMCID: PMC4964982          DOI: 10.1002/anie.201510557

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  24 in total

1.  Stapled peptides for intracellular drug targets.

Authors:  Gregory L Verdine; Gerard J Hilinski
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

4.  Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

Authors:  Shunqiang Li; Dong Shen; Jieya Shao; Robert Crowder; Wenbin Liu; Aleix Prat; Xiaping He; Shuying Liu; Jeremy Hoog; Charles Lu; Li Ding; Obi L Griffith; Christopher Miller; Dave Larson; Robert S Fulton; Michelle Harrison; Tom Mooney; Joshua F McMichael; Jingqin Luo; Yu Tao; Rodrigo Goncalves; Christopher Schlosberg; Jeffrey F Hiken; Laila Saied; Cesar Sanchez; Therese Giuntoli; Caroline Bumb; Crystal Cooper; Robert T Kitchens; Austin Lin; Chanpheng Phommaly; Sherri R Davies; Jin Zhang; Megha Shyam Kavuri; Donna McEachern; Yi Yu Dong; Cynthia Ma; Timothy Pluard; Michael Naughton; Ron Bose; Rama Suresh; Reida McDowell; Loren Michel; Rebecca Aft; William Gillanders; Katherine DeSchryver; Richard K Wilson; Shaomeng Wang; Gordon B Mills; Ana Gonzalez-Angulo; John R Edwards; Christopher Maher; Charles M Perou; Elaine R Mardis; Matthew J Ellis
Journal:  Cell Rep       Date:  2013-09-19       Impact factor: 9.423

5.  Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.

Authors:  C y Chang; J D Norris; H Grøn; L A Paige; P T Hamilton; D J Kenan; D Fowlkes; D P McDonnell
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Authors:  Yong S Chang; Bradford Graves; Vincent Guerlavais; Christian Tovar; Kathryn Packman; Kwong-Him To; Karen A Olson; Kamala Kesavan; Pranoti Gangurde; Aditi Mukherjee; Theresa Baker; Krzysztof Darlak; Carl Elkin; Zoran Filipovic; Farooq Z Qureshi; Hongliang Cai; Pamela Berry; Eric Feyfant; Xiangguo E Shi; James Horstick; D Allen Annis; Anthony M Manning; Nader Fotouhi; Huw Nash; Lyubomir T Vassilev; Tomi K Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

7.  The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer.

Authors:  Michelle L Stewart; Emiko Fire; Amy E Keating; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2010-06-20       Impact factor: 15.040

Review 8.  Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.

Authors:  Marta Pelay-Gimeno; Adrian Glas; Oliver Koch; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-26       Impact factor: 15.336

9.  Crystal structures of stapled and hydrogen bond surrogate peptides targeting a fully buried protein-helix interaction.

Authors:  Christopher H Douse; Sabrina J Maas; Jemima C Thomas; James A Garnett; Yunyun Sun; Ernesto Cota; Edward W Tate
Journal:  ACS Chem Biol       Date:  2014-08-06       Impact factor: 5.100

10.  ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.

Authors:  Weiyi Toy; Yang Shen; Helen Won; Bradley Green; Rita A Sakr; Marie Will; Zhiqiang Li; Kinisha Gala; Sean Fanning; Tari A King; Clifford Hudis; David Chen; Tetiana Taran; Gabriel Hortobagyi; Geoffrey Greene; Michael Berger; José Baselga; Sarat Chandarlapaty
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

View more
  15 in total

1.  Palladium Oxidative Addition Complexes for Peptide and Protein Cross-linking.

Authors:  Koji Kubota; Peng Dai; Bradley L Pentelute; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2018-02-13       Impact factor: 15.419

Review 2.  Steroid receptor/coactivator binding inhibitors: An update.

Authors:  Kornelia J Skowron; Kenneth Booker; Changfeng Cheng; Simone Creed; Brian P David; Phillip R Lazzara; Amy Lian; Zamia Siddiqui; Thomas E Speltz; Terry W Moore
Journal:  Mol Cell Endocrinol       Date:  2019-06-01       Impact factor: 4.102

3.  Using Tumor Explants for Imaging Mass Spectrometry Visualization of Unlabeled Peptides and Small Molecules.

Authors:  Brian P David; Oleksii Dubrovskyi; Thomas E Speltz; Jeremy J Wolff; Jonna Frasor; Laura M Sanchez; Terry W Moore
Journal:  ACS Med Chem Lett       Date:  2018-05-17       Impact factor: 4.345

4.  Computational Estimation of Microsecond to Second Atomistic Folding Times.

Authors:  Upendra Adhikari; Barmak Mostofian; Jeremy Copperman; Sundar Raman Subramanian; Andrew A Petersen; Daniel M Zuckerman
Journal:  J Am Chem Soc       Date:  2019-04-12       Impact factor: 15.419

5.  A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction.

Authors:  Thomas E Speltz; Jeanne M Danes; Joshua D Stender; Jonna Frasor; Terry W Moore
Journal:  ACS Chem Biol       Date:  2018-01-24       Impact factor: 5.100

6.  Protein Crosslinking by Genetically Encoded Noncanonical Amino Acids with Reactive Aryl Carbamate Side Chains.

Authors:  Weimin Xuan; Sida Shao; Peter G Schultz
Journal:  Angew Chem Int Ed Engl       Date:  2017-04-03       Impact factor: 15.336

7.  A "cross-stitched" peptide with improved helicity and proteolytic stability.

Authors:  Thomas E Speltz; Christopher G Mayne; Sean W Fanning; Zamia Siddiqui; Emad Tajkhorshid; Geoffrey L Greene; Terry W Moore
Journal:  Org Biomol Chem       Date:  2018-05-23       Impact factor: 3.876

8.  Versatile Peptide Macrocyclization with Diels-Alder Cycloadditions.

Authors:  Jeffrey E Montgomery; Justin A Donnelly; Sean W Fanning; Thomas E Speltz; Xianghang Shangguan; John S Coukos; Geoffrey L Greene; Raymond E Moellering
Journal:  J Am Chem Soc       Date:  2019-09-26       Impact factor: 15.419

9.  Chiral Sulfoxide-Induced Single Turn Peptide α-Helicity.

Authors:  Qingzhou Zhang; Fan Jiang; Bingchuan Zhao; Huacan Lin; Yuan Tian; Mingsheng Xie; Guoyun Bai; Adam M Gilbert; Gilles H Goetz; Spiros Liras; Alan A Mathiowetz; David A Price; Kun Song; Meihua Tu; Yujie Wu; Tao Wang; Mark E Flanagan; Yun-Dong Wu; Zigang Li
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

10.  Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer.

Authors:  Balkees Abderrahman; Philipp Y Maximov; Ramona F Curpan; Sean W Fanning; Jay S Hanspal; Ping Fan; Charles E Foulds; Yue Chen; Anna Malovannaya; Antrix Jain; Rui Xiong; Geoffrey L Greene; Debra A Tonetti; Gregory R J Thatcher; V Craig Jordan
Journal:  Mol Cancer Ther       Date:  2020-11-11       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.